Israel Englander’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-75,000
Closed -$6.69M 4239
2017
Q3
$6.69M Buy
75,000
+18,900
+34% +$1.44M 0.01% 1505
2017
Q2
$3.35M Buy
+56,100
New +$3.13M 0.01% 1763

Israel Englander's ONCE Position: Q4 2019 in Review

Israel Englander sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 493,633 shares — an estimated $47.9M sold.

Israel Englander first reported a position in ONCE in Q2 2015 and held it in 14 quarters. The position peaked at $75.5M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Israel Englander reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Israel Englander sold 493,633 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $47.9M.
  • Israel Englander first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and held it in 14 quarters.
  • Israel Englander's Spark Therapeutics, Inc. Common Stock position peaked at $75.5M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.